The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
nycomed | 564 |
takeda | 504 |
nycomed pharma | 77 |
takeda nycomed | 72 |
altana pharma | 50 |
astrazeneca | 25 |
takeda pharmaceutical company | 23 |
amgen research (munich) | 18 |
wyeth | 12 |
nycomed asset management | 7 |
nycomed | 82 |
nycomed pharma | 11 |
altana pharma | 7 |
wyeth | 4 |
takeda | 3 |
nicomede company | 1 |
byk gulden lomberg chemische fabrik | 1 |
autenna medicines | 1 |
toshiba corporation | 1 |
astrazeneca | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors | 61 | 2004 |
combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the … 🛈 | 55 | 2006 |
pyrazolone derivatives as pde4 inhibitors | 50 | 2007 |
ophthalmological use of roflumilast for the treatment of diseases of the eye | 50 | 2002 |
rolled collagen carrier | 49 | 2011 |
oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrro… 🛈 | 40 | 2002 |
3,4,4a,10b-tetrahydro-1h-thiopyrano-[4, 3-c] isoquinoline derivatives | 39 | 2009 |
film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceut… 🛈 | 39 | 2005 |
dosage form containing pantoprazole as active ingredient | 38 | 2003 |
carrier with solid fibrinogen and solid thrombin | 34 | 2001 |